Versigent (NYSE:VGNT) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of Versigent (NYSE:VGNT) to a hold rating in a report released on Thursday morning,Zacks.com reports.

Other research analysts also recently issued research reports about the company. Fox Advisors raised Versigent to a “strong-buy” rating in a research note on Tuesday, April 7th. TD Cowen initiated coverage on shares of Versigent in a report on Tuesday. They issued a “buy” rating and a $47.00 target price on the stock. Wells Fargo & Company began coverage on shares of Versigent in a research report on Monday, April 6th. They issued an “overweight” rating and a $35.00 target price for the company. UBS Group began coverage on shares of Versigent in a report on Tuesday. They set a “buy” rating and a $43.00 price target for the company. Finally, Royal Bank Of Canada began coverage on shares of Versigent in a research report on Tuesday, March 31st. They set a “sector perform” rating and a $28.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $38.25.

Versigent Stock Performance

VGNT opened at $34.69 on Thursday. Versigent has a 52-week low of $26.34 and a 52-week high of $35.08.